Drug treatment of COVID-19 infection
G Lui, G Guaraldi - Current Opinion in Pulmonary Medicine, 2023 - journals.lww.com
G Lui, G Guaraldi
Current Opinion in Pulmonary Medicine, 2023•journals.lww.com… This review focuses on recent data from randomized trials and postmarketing real-world
evidence for the treatment of mild to moderate disease in the outpatient setting and patients
hospitalized for COVID-19 with varying level of severity. Relevant data for treatment of the
latest omicron sub-variants in people who received vaccination are presented. Challenges in
special populations, including immunocompromised hosts, patients with renal failure and
pregnant women, are also discussed. … This review focuses on recent data on drug treatment …
evidence for the treatment of mild to moderate disease in the outpatient setting and patients
hospitalized for COVID-19 with varying level of severity. Relevant data for treatment of the
latest omicron sub-variants in people who received vaccination are presented. Challenges in
special populations, including immunocompromised hosts, patients with renal failure and
pregnant women, are also discussed. … This review focuses on recent data on drug treatment …
Summary
Treatment of COVID-19 should be personalized according to host characteristics, degree of severity and available treatment options.
Lippincott Williams & Wilkins以上显示的是最相近的搜索结果。 查看全部搜索结果